Generate a tailored SOP for Dr. Thales Papagiannakopoulos. Improve your application with a focused, well-structured draft.
Thales Y. Papagiannakopoulos is an Associate Professor in the Department of Pathology at New York University. His research focuses on the development of novel in vivo genome engineering approaches to cancer research, particularly lung cancer. His lab is pioneering the use of genetically engineered mouse models (GEMMs) combined with CRISPR/Cas9 technologies to systematically interrogate the complex catalog of mutations identified in cancer genome sequencing studies. Papagiannakopoulos’ work aims to elucidate the role of physiological and metabolic factors in lung tumorigenesis and to develop personalized, genotype-based therapies for cancer treatment. His extensive contributions to the field enhance understanding of the biological underpinnings of cancer and offer pathways towards the precision medicine of the future. Papagiannakopoulos holds a PhD from the University of California, Santa Barbara, and has received advanced training from Massachusetts Institute of Technology, focusing on the unique vulnerabilities of cancer cells and optimizing therapeutic approaches to halt tumor progression.
New York University • New York, NY
Teaching and conducting research in pathology with a focus on cancer research.
Open Program in Biomedical Sciences (Vilcek Institute) covers departments like Biochemistry, Pathology, Neuroscience, Microbiology, etc.